Trial Profile
A Study to Evaluate the Safety and Efficacy of Midostaurin in Patients with Aggressive Systemic Mastocytosis (ASM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Midostaurin (Primary)
- Indications Systemic mastocytosis
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 19 Dec 2015 New trial record